Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the popular anti-obesity…
Read More »Diabetes
Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…
Read More »
Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals…
Read More »
When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due…
Read More »
The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…
Read More »
New findings show that abnormal sleep durations, either too short or too long, significantly elevate the risk of microvascular complications…
Read More »
A comprehensive study across diverse populations linked specific bacterial strains and bacteriophages within the gut microbiome to type 2 diabetes…
Read More »
Researchers found that evening physical activity had a significant positive impact on glucose regulation in overweight and obese adults. This…
Read More »
Research from Geisinger Medical Center shows Roux-en-Y gastric bypass surgery holds type 2 diabetes in remission for 15 years and…
Read More »
Patients with prediabetes and severe obesity who underwent metabolic surgery, such as Roux-en-Y gastric bypass or sleeve gastrectomy, significantly reduced…
Read More »